MedPage Today8h
FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
Sanofi gets FDA approval for NovoLog insulin biosimilar
Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...
Healthline2d
Type 2 Diabetes
Over time, you might need to add other oral meds, insulin, or other injectable drugs, like a GLP-1 receptor agonist, to your treatment plan. You might be able to manage your blood sugar with ...
The Washington Missourian4d
Goodbye Needles, Hello Convenience: Exploring Compounded Semaglutide
"Adherence improves when treatment integrates easily into patients’ lives," explains Adam McBride, Eden’s CEO. Eden’s digital platform streamlines access to independent healthcare professionals who ...